|

Anti-VEGF 7.5mg/kg Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Zhejiang Cancer Hospital1

Indications

  • Liver Disease1
  • Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric Adenocarcinoma1
  • Biliary Tract Carcinoma1
  • Colorectal Adenocarcinoma1
  • Liver Cancer1

Other1 trial

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.